← board
MYGN
distress 3/10 · well-funded / low risk$5.68+0%today-31% from 52w high
Revenue
$200M
Liquidity
$124M
Runway
—
Shares 1y
+2%
Price & events
-6.3% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.4%
1D
-8.2%
1W
+22.7%
1M
+18.6%
3M
-3.2%
6M
+19.8%
1Y
-79.7%
2Y
-82.1%
5Y
-71.5%
All
Overview
- Market Cap
- $536.47M
- Enterprise Value
- $532.37M
- Volume
- 99.25K
- 52 Week Range
- $3.55 – $8.18
- Total Shares
- 94.45M
- Float Shares
- 85.99M
- Short %
- 9.30%
- % Held by Insiders
- 3.76%
- % Held by Institutions
- 95.77%
- RVOL
- 0.07x
- Beta
- 1.64
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 3
- 2026-07-30Estimated 45%earningsEarningsEarnings releaseyahoo
- 2025-07-31partnershipEntered into a $200 million senior secured term loan credit facility with OrbiMedSEC 8-K
- 2024-09-04trial discontinuedGeneSight · Discontinued analysis of part two of economic utility study due to unreliable matched control group.SEC 8-K
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
hold · target $6 (+10% upside) · 8 analysts
- 2026-05-06Wells FargoEqual-Weight
- 2026-05-06TD CowenHold
- 2026-02-24UBSNeutral
- 2026-02-24Wells FargoEqual-Weight
- 2025-11-11Piper SandlerOverweight
- 2025-11-05Wells FargoEqual-Weight
Competitors
- none identified
Recent news
- 2026-07-23Myriad Genetics to Hold Second Quarter 2026 Earnings Conference Call on July 30 - Quiver Quantitative
- 2026-07-23Myriad Genetics to Webcast Q2 Business Update July 30 - Stock Titan
- 2026-07-23Myriad Genetics to Release Second Quarter 2026 Financial Results on July 30, 2026 - Yahoo Finance Singapore
- 2026-07-21Myriad Genetics launches prenatal genetic screening test By Investing.com - Investing.com Nigeria
- 2026-07-21Myriad Genetics launches prenatal genetic screening test By Investing.com - Investing.com Canada
- 2026-07-21Myriad Genetics Launches FirstGene® Multiple Prenatal Screen - GlobeNewswire
- 2026-07-21Myriad's one-draw test runs four prenatal screens at 8 weeks - Stock Titan
- 2026-07-21Myriad Genetics Launches FirstGene® Multiple Prenatal Screen - GlobeNewswire
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.